Imagion Biosystems Limited (Company) is committed to ensuring that public confidence is maintained in the Company, its people and the trading of its securities. This policy sets out the company’s trading policy on buying and selling securities of the Company including shares, options, derivatives, managed investment products, superannuation products and any other financial products of the Company that are able to be traded on a financial market (Company’s Securities).
View the Imagion Biosystems Limited Securities Trading Policy.
The Stock Network Interview – How MagSense® is moving towards Phase 2 clinical trials
Lel Smits from The Stock Network sat down with Imagion Biosystems’ Bob Proulx to discuss how the company is moving through the critical steps required
